News

US FDA chief says firings won't hinder agency's target dates for drug reviews
The U.S. Food and Drug Administration will meet its targets for completing reviews of new drugs despite mass firings at the ...
FDA to undo some layoffs, after cuts to inspections and drug safety
Multiple current and laid-off FDA employees said the abrupt layoffs had resulted in delays and disruptions to the agency's ...
Big change could be coming to Flamin’ Hot Cheetos, Skittles and more popular snacks
The Food and Drug Administration is phasing out the use of petroleum-based synthetic dyes by the end of 2026 - a change that ...
STAT15h
Amid FDA chaos, approval of a rare disease drug gets delayed — again
Stealth BioTherapeutics had expected the FDA to respond on Tuesday to its marketing application for elamipretide to treat ...
Major food brands will stop using artificial dyes. Here’s why RFK is sounding the alarm
A series of studies have raised concerns by associating synthetic food colorings with health risks from hyperactivity to ...
STAT13h
Pharmalittle: We’re reading about FDA chaos delaying a rare disease drug, Merck’s U.S. investment, and more
Merck will grow its U.S. manufacturing footprint with a $1 billion plant, making it the latest drugmaker to invest in the U.S ...
How bugs and beet juice could play roles in the race to replace artificial dyes in food
As pressure grows to get artificial colors out of the U.S. food supply, the shift may well start at Abby Tampow’s laboratory ...
FDA Suspends Milk Quality Testing And Food Safety Quality Checks Due To Staff Cuts
The Food and Drug Administration (FDA) revealed some troubling news over the past week. Due to staff cuts, it is suspending a ...
Arizona Daily Sun16h
FDA delays decision on Stealth BioTherapeutics' rare genetic disorder drug
The U.S. Food and Drug Administration has delayed its decision on marketing approval for Stealth BioTherapeutics' treatment ...
FDA announces ban for compounded weight loss drugs
Recently, the FDA announced the removal of certain compounded GLP1 ingredients from its drug shortage list. These ingredients ...
Reuters13d
U.S. Food and Drug Administration
Future of Healthcategory· April 18, 2025 Sanofi-Regeneron's Dupixent gets FDA's nod for skin condition The U.S. Food and Drug Administration approved the use of Sanofi and Regeneron's blockbuster ...